drugset / Trial / NCT00930332
Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain
Non-randomizedSingle-groupOpen-labelSupportive care
Summary
RATIONALE: Methadone hydrochloride may reduce chronic neuropathic pain in patients with cancer. PURPOSE: This phase I trial is studying the side effects and best dose of methadone hydrochloride as first-line therapy in treating patients with chronic neuropathic cancer pain.
Timeline
- Start
- 2010-06-17
- Primary completion
- 2012-01-06
- Completion
- 2012-01-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methadone | Other / unclassified | 1 mg | Oral |
| Comparator | Methadone | Other / unclassified | 2 mg | Oral |
| Comparator | Methadone | Other / unclassified | 3 mg | Oral |
| Comparator | Methadone | Other / unclassified | 4 mg | Oral |